arrow
S

Sabine C. Linn

Netherlands Cancer Institute
H指数:65
被引数:1.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of Reimbursement on the Utilisation of Gene Expression Profiles and Chemotherapy Decision-Making in Dutch Breast Cancer Patients: A Population-Based Study

报销对荷兰乳腺癌患者基因表达谱的利用和化疗决策的影响: 一项基于人群的研究

2026-06-040
OAAI
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancer

标签高效的计算肿瘤浸润淋巴细胞评估在乳腺癌中的应用(ECTIL):在2340例乳腺癌患者中的多中心验证

2025-12-100
OAAI
Safety of having a subsequent pregnancy after prior diagnosis of breast cancer during pregnancy in young BRCA carriers

年轻BRCA携带者在孕期被诊断患有乳腺癌后,再次怀孕的安全性

2025-08-130
OAAI
Worse prognosis for breast cancer diagnosed in advanced pregnancy and shortly postpartum: an update of the Dutch pregnancy-associated breast cancer cohort

晚期妊娠及产后不久确诊的乳腺癌预后更差:荷兰妊娠相关乳腺癌队列研究的更新

2025-08-120
OAAI
Breastfeeding after breast cancer in young BRCA carriers

Blondeaux, E.; Delucchi, V.; Mariamidze, E.; Bernstein-Molho, R.; Frank, S.; Ferrari, A.; Linn, S.; Jeong Kim, H.; Agostinetto, E.; Paluch-Shimon, S.; 等. 乳腺癌后母乳喂养在年轻BRCA携带者中的应用. J. Natl. Cancer Inst. 2025, djaf177. [Google Scholar] [CrossRef] [PubMed]

2025-08-012
OAAI
Prognostication and treatment predictions for estrogen receptor positive early-stage breast cancer: incorporating the 70-gene signature into the PREDICT prognostication model

雌激素受体阳性早期乳腺癌的预后和治疗预测:将70基因签名整合到PREDICT预后模型中

2025-07-190
PREAI
Breast implant illness after reconstruction with silicone breast implants

硅凝胶乳房植入物重建后的乳房植入物相关疾病

2025-07-014
OA
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC

乳腺癌并发软脑膜转移患者的临床特征与预后因素:来自BMBC大型注册研究的数据

BREAST
IF7.9
2025-06-010
OAAI
Genetic Alterations, Therapy Response, and Survival Among Patients With Triple-Negative Breast Cancer A Secondary Analysis of a Randomized Clinical Trial

三阴性乳腺癌患者中的基因改变、治疗反应和生存情况:一项随机临床试验的二次分析

2025-02-260
OA
Characteristics and clinical outcomes of breast cancer in young BRCA carriers according to tumor histology
2024-10-010
OAAI
Neoadjuvant nivolumab or nivolumab plus ipilimumab in early-stage triple-negative breast cancer: a phase 2 adaptive trial

新辅助nivolumab或nivolumab联合ipilimumab治疗早期三阴性乳腺癌: 2期适应性试验

2024-09-162
OAAI
Breastfeeding after breast cancer in young BRCA carriers: Results from an international cohort study

乳腺癌年轻BRCA携带者产后哺乳:一项国际队列研究的结果

2024-09-010
PRE
First-line carboplatin-cyclophosphamide (CC) versus paclitaxel (P) with or without atezolizumab (atezo) for metastatic triple negative breast cancer (mTNBC): Results from a multicenter, randomized phase IIb trial: The Triple-B study (BOOG 2013-01)

卡铂-环磷酰胺(CC)一线方案与紫杉醇(P)联合或不联合阿特珠单抗(atezo)治疗转移性三阴性乳腺癌(mTNBC)的对比:一项多中心、随机IIb期试验的结果:Triple-B研究(BOOG 2013-01)

2024-09-010
PRE
Brain imaging screening (BIS) in metastatic breast cancer (MBC): Patients' and physicians' perspectives

脑成像筛查(BIS)在转移性乳腺癌(MBC)中的应用:患者与医生的视角

2024-09-010
PRE
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study
CANCER
IF5.1
2024-05-166
OAAI